Patents by Inventor Friedhelm BLOBEL

Friedhelm BLOBEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER WITH IMMUNE STIMULATORS
    Publication number: 20230285513
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Application
    Filed: December 12, 2022
    Publication date: September 14, 2023
    Inventors: Robert S. KING, Cynthia W. TUTHILL, Friedhelm BLOBEL
  • Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
    Patent number: 11571465
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: February 7, 2023
    Assignee: SciClone Pharmaceuticals International Ltd.
    Inventors: Robert S. King, Cynthia W. Tuthill, Friedhelm Blobel
  • TREATMENT OF CANCER WITH IMMUNE STIMULATORS
    Publication number: 20200289618
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Application
    Filed: January 7, 2020
    Publication date: September 17, 2020
    Inventors: Robert S. KING, Cynthia W. TUTHILL, Friedhelm BLOBEL
  • TREATMENT OF CANCER WITH IMMUNE STIMULATORS
    Publication number: 20180161399
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Application
    Filed: July 5, 2017
    Publication date: June 14, 2018
    Inventors: Robert S. KING, Cynthia W. TUTHILL, Friedhelm BLOBEL
  • Treatment of cancer with immune stimulators
    Patent number: 9724395
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: August 8, 2017
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Robert S. King, Cynthia W. Tuthill, Friedhelm Blobel
  • TREATMENT OF CANCER WITH IMMUNE STIMULATORS
    Publication number: 20160106812
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Application
    Filed: October 21, 2015
    Publication date: April 21, 2016
    Inventors: Robert S. KING, Cynthia W. TUTHILL, Friedhelm BLOBEL